Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma

Lung adenocarcinoma (LUAD), the most prevalent subtype of non-small cell lung cancer, is a significant cause of cancer-related mortality due to late-stage diagnoses and limited treatment options. Identifying effective biomarkers is crucial for improving prognosis and therapeutic strategies. miR-30a-...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunus Sahin, Zekiye Altan, Khandakar A.S.M. Saadat, Masa-Aki Ikeda, Ahmet Arslan
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580825002092
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849320279302471680
author Yunus Sahin
Zekiye Altan
Khandakar A.S.M. Saadat
Masa-Aki Ikeda
Ahmet Arslan
author_facet Yunus Sahin
Zekiye Altan
Khandakar A.S.M. Saadat
Masa-Aki Ikeda
Ahmet Arslan
author_sort Yunus Sahin
collection DOAJ
description Lung adenocarcinoma (LUAD), the most prevalent subtype of non-small cell lung cancer, is a significant cause of cancer-related mortality due to late-stage diagnoses and limited treatment options. Identifying effective biomarkers is crucial for improving prognosis and therapeutic strategies. miR-30a-5p has emerged as a potential tumor suppressor in LUAD, yet its exact role remains unclear. In this study, we analyzed three miRNA expression datasets from the GEO database and confirmed miR-30a downregulation in LUAD through TCGA and qRT-PCR validation. We identified MYBL2, TWF1, GALNT7, and PFN2 as oncogenic targets of miR-30a by integrating miRNA target predictions with gene expression data. Expression and survival analyses revealed an inverse relationship between miR-30a and these targets, with high expression levels correlating with poor patient outcomes. Functional enrichment analysis highlighted pathways in cell cycle regulation and actin cytoskeleton organization. Our findings underscore the significance of the miR-30a regulatory network in LUAD progression, positioning miR-30a and its targets as promising prognostic biomarkers and therapeutic targets.
format Article
id doaj-art-c550d44f0e0e4c6ca70cd9652ad244fb
institution Kabale University
issn 2405-5808
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series Biochemistry and Biophysics Reports
spelling doaj-art-c550d44f0e0e4c6ca70cd9652ad244fb2025-08-20T03:50:07ZengElsevierBiochemistry and Biophysics Reports2405-58082025-09-014310212210.1016/j.bbrep.2025.102122Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinomaYunus Sahin0Zekiye Altan1Khandakar A.S.M. Saadat2Masa-Aki Ikeda3Ahmet Arslan4Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Corresponding author.Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep, TurkeyDepartment of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep, TurkeyDepartment of Molecular Craniofacial Embryology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, JapanDepartment of Medical Genetics, Faculty of Medicine, Research and Application Hospital, Tekirdag Namık Kemal University, Suleymanpasa, Tekirdag, TurkeyLung adenocarcinoma (LUAD), the most prevalent subtype of non-small cell lung cancer, is a significant cause of cancer-related mortality due to late-stage diagnoses and limited treatment options. Identifying effective biomarkers is crucial for improving prognosis and therapeutic strategies. miR-30a-5p has emerged as a potential tumor suppressor in LUAD, yet its exact role remains unclear. In this study, we analyzed three miRNA expression datasets from the GEO database and confirmed miR-30a downregulation in LUAD through TCGA and qRT-PCR validation. We identified MYBL2, TWF1, GALNT7, and PFN2 as oncogenic targets of miR-30a by integrating miRNA target predictions with gene expression data. Expression and survival analyses revealed an inverse relationship between miR-30a and these targets, with high expression levels correlating with poor patient outcomes. Functional enrichment analysis highlighted pathways in cell cycle regulation and actin cytoskeleton organization. Our findings underscore the significance of the miR-30a regulatory network in LUAD progression, positioning miR-30a and its targets as promising prognostic biomarkers and therapeutic targets.http://www.sciencedirect.com/science/article/pii/S2405580825002092Lung adenocarcinomamiR-30aPrognostic biomarkersMicroRNABioinformatics
spellingShingle Yunus Sahin
Zekiye Altan
Khandakar A.S.M. Saadat
Masa-Aki Ikeda
Ahmet Arslan
Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma
Biochemistry and Biophysics Reports
Lung adenocarcinoma
miR-30a
Prognostic biomarkers
MicroRNA
Bioinformatics
title Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma
title_full Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma
title_fullStr Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma
title_full_unstemmed Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma
title_short Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma
title_sort investigating mir 30a s tumor suppressor role and its targets mybl2 twf1 galnt7 pfn2 as prognostic biomarkers in lung adenocarcinoma
topic Lung adenocarcinoma
miR-30a
Prognostic biomarkers
MicroRNA
Bioinformatics
url http://www.sciencedirect.com/science/article/pii/S2405580825002092
work_keys_str_mv AT yunussahin investigatingmir30astumorsuppressorroleanditstargetsmybl2twf1galnt7pfn2asprognosticbiomarkersinlungadenocarcinoma
AT zekiyealtan investigatingmir30astumorsuppressorroleanditstargetsmybl2twf1galnt7pfn2asprognosticbiomarkersinlungadenocarcinoma
AT khandakarasmsaadat investigatingmir30astumorsuppressorroleanditstargetsmybl2twf1galnt7pfn2asprognosticbiomarkersinlungadenocarcinoma
AT masaakiikeda investigatingmir30astumorsuppressorroleanditstargetsmybl2twf1galnt7pfn2asprognosticbiomarkersinlungadenocarcinoma
AT ahmetarslan investigatingmir30astumorsuppressorroleanditstargetsmybl2twf1galnt7pfn2asprognosticbiomarkersinlungadenocarcinoma